Cardiovascular safety with linagliptin in patients with type 2 diabetes mellitus: a pre-specified, prospective, and adjudicated meta-analysis of a phase 3 programme - Johansen, O E; Neubacher, D; von Eynatten, M (Cardiovasc Diabetol, 2012)
et al.